Angelo, I totally agree. I too think the china deal is for manufacturing and distribution for Glucho and Keppra in China and then see what else may come.
One thing I noticed is Shanghai Pharma just bought out a china distribution company for 1.2 billion in November. Smart Pharma just opened the manufacturing site in china. what is lacking? the drugs!
technically any of the approved drugs would be fair game. I also saw Shanghai announced Friday a 400 million dollar closed offering to private investors to be used for manufacturing and distribution endeavors. The only thing we do not know are the actual details and how much money upfront and if any went to IPCI.
I think its going to be good for IPCI but at this point we just dont know the details.
News 
Market Data 
Discover 
